Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome

March 12, 2024 updated by: Thomas Gross, MD, Kantonsspital Aarau

Quality Control in the Management of Major Trauma Patients at Aarau Cantonal Hospital - Evaluation of Processes and Patient Outcome

Quality control and improvement project: Assessment and analysis of processes and outcome in trauma emergency room and major trauma patients at the Aarau trauma center (cantonal hospital) with regard to initial emergency management, hospital processes and short- and long-term (1-and 2-year) outcome of patients (subjective and objective). Comparison of processes and outcome pre- and post- project initiative. Benchmarking with the literature and by participation in the German and Swiss Trauma registry each.

Study Overview

Status

Completed

Conditions

Detailed Description

Registry of all emergency patients arriving at Aarau trauma center following trauma with regard to possibly injury related pre- and inhospital demographic factors, process variables and outcome Parameters.

Study Type

Observational

Enrollment (Actual)

3800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • Aargau
      • Aarau, Aargau, Switzerland, 5001
        • Aarau Cantonal Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All emergency patients treated at Aarau Cantonal Hospital following trauma (<24h postinjury) with suspected major trama

Description

Inclusion Criteria:

  • major trauma: New Injury Severity Score (NISS) >=8
  • for longer-term outcome: only patients firm in German language and able to respond to the postal questionnaire by themselves

Exclusion Criteria:

  • no Trauma
  • injury >24h before arrival at Aarau Cantonal Hospital
  • NISS<8
  • for longer-term outcome: patients not firm in German language and not able to respond to the postal questionnaire by themselves (dead, unavailable, refusal to participate, dementia, age<16 years ecc.); a categorising compilation of cases is supposed to exclude any possible study bias

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
trauma patients
type and severity of patients, circumstances and trauma pre- and post-injury / -quality initiative

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
emergency room process times
Time Frame: hours (<6)
hours (<6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hospital mortality
Time Frame: 30 days
30 days
Euro Quality of Life Group health-related quality of life on five dimensions (EQ-5D)
Time Frame: 1 and 2 year follow-up
score
1 and 2 year follow-up
Trauma Outcome Profile (TOP)
Time Frame: 1 and 2 year follow-up
score
1 and 2 year follow-up
Quality of Life after Brain Injury (QOLIBRI)
Time Frame: 1 and 2 year follow-up
score
1 and 2 year follow-up
medical outcomes study Short Form-36 (SF-36)
Time Frame: 1 and 2 year follow-up
score
1 and 2 year follow-up
reduced capacity to work
Time Frame: 1 and 2 year outcome
Value (%);e.g. see Gross T, Attenberger C, Huegli RW, Amsler F. Factors associated with reduced longer-term capacity to work in patients after polytrauma: a Swiss trauma center experience. J Am Coll Surg. 2010 Jul;211(1):81-91
1 and 2 year outcome

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
invalidity
Time Frame: at least 4 year post-injury
% of disability to work (i.e., basis for resulting amount of insurance pension)
at least 4 year post-injury
insurance payments
Time Frame: at least 4 years post-injury
Swiss Francs
at least 4 years post-injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kantonsspital Aarau

Collaborators

Kantonsspital Aarau, Wissenschaftlicher Fond
Suva

Investigators

  • Principal Investigator: Thomas Gross, MD, Prof., Aarau Cantonal Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

June 11, 2014

First Submitted That Met QC Criteria

June 13, 2014

First Posted (Estimated)

June 17, 2014

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2012-008 (Other Identifier: Kantonale Ethikkommission AG/ SO)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe